Lower-Dose Therapy Is Associated with Fewer Serious Adverse Events in Elders with Systemic Necrotizing Vasculitis

Summary and Comment |
May 5, 2015

Lower-Dose Therapy Is Associated with Fewer Serious Adverse Events in Elders with Systemic Necrotizing Vasculitis